Quinoline derivatives as AXL kinase inhibitors

Novel compounds which are inhibitors of receptor tyrosine kinases of the AXL receptor family are described herein. These compounds are suitable for the treatment or prevention of disorders associated with, accompanied by or caused by hyperfunction of a receptor of the AXL family. The compounds are s...

Full description

Saved in:
Bibliographic Details
Main Authors KNYAZEV PJOTR, ÖRFI LÁSZLÓ, ZHANG YIXIANG, SZABADKAI ISTVÁN, ULLRICH AXEL, GYÖRGY KÉRI
Format Patent
LanguageEnglish
Published 08.12.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Novel compounds which are inhibitors of receptor tyrosine kinases of the AXL receptor family are described herein. These compounds are suitable for the treatment or prevention of disorders associated with, accompanied by or caused by hyperfunction of a receptor of the AXL family. The compounds are suitable for the treatment of hyperproliferative disorders, such as cancer, particularly cancer metastases.
Bibliography:Application Number: US20090933070